Exclusive

Publication

Byline

Singapore accelerates access to health innovations across Africa, Malaysia and Saudi Arabia

Singapore, Sept. 18 -- Singapore's regulatory body Health Sciences Authority (HSA) is expanding reliance and cooperation across Africa, Malaysia and Saudi Arabia to reduce duplicated reviews, support ... Read More


Australia-US partnership to drive global health research innovation

Singapore, Sept. 18 -- Australia's Monash University has collaboratd with Weill Cornell Medicine, Cornell University's academic medical institution, to tackle new research projects including mental he... Read More


US health tech company Massive Bio expands Asia footprint with South Korea market push

Singapore, Sept. 18 -- US health tech company Massive Bio has appointed international business development consultancy Intralink to support its expansion into South Korea and build partnerships across... Read More


Japan's Takeda Pharma partners with Dr. Reddy's Labs for dengue vaccine distribution in India

Singapore, Sept. 18 -- Japan-based Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India, and Dr. Reddy's Laboratories, have entered into a distribution agreemen... Read More


Leica Biosystems advances histology workflow efficiency with new high-speed laser cassette printer

Singapore, Sept. 18 -- Germany headquartered Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, reinforces its commitment to connected path... Read More


Japan approves LEQEMBI Pen for at-home treatment of early Alzheimer's disease

Singapore, Sept. 18 -- Eisai and Biogen have received approval in Japan for LEQEMBI Pen, a subcutaneous autoinjector formulation of lecanemab for the treatment of early Alzheimer's disease. The appro... Read More


Lundbeck wins Japan approval for Vyepti in migraine prevention

Singapore, Sept. 18 -- Lundbeck has received marketing authorisation from Japan's Ministry of Health, Labour and Welfare for Vyepti, or eptinezumab, for the prevention of migraine attacks in adults. ... Read More


Akeso receives China Phase I clearance for EGFR/TROP2 bispecific ADC AK158D1

Singapore, Sept. 18 -- Akeso has received clearance from the Center for Drug Evaluation under China's National Medical Products Administration to initiate a Phase I clinical trial of AK158D1 in patien... Read More


IASO Bio receives FDA IND clearance for CD20-targeted in vivo CAR-T therapy

Singapore, Sept. 18 -- IASO Biotechnology has received US Food and Drug Administration clearance for the Investigational New Drug application of IASO208, its CD20-targeted in vivo CAR-T therapy. IASO... Read More


Ashok Leyland Ties Up With Kerala Grameena Bank For End-To-End Vehicle Financing

Mumbai, Sept. 18 -- Ashok Leyland, the Hinduja Group's Indian flagship and a leading commercial vehicle manufacturer, has entered a strategic vehicle financing partnership with Kerala Grameena Bank th... Read More